ubiquitin ligase inhibitors (Proteologics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameubiquitin ligase inhibitors (Proteologics)
Drug Alias Nameubiquitin ligase inhibitors (Proteologics)5081473
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin-protein ligases inhibitors
TargetsUbiquitin-protein ligases
Therapy Area/IndicationsVirus DiseasesHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProteologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProteologics Inc
Active IndicationsN/A
Inactive IndicationsVirus DiseasesHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A